Female Androgenetic Alopecia Without Hyperandrogenism: What to Do When Topical Minoxidil Has Not Achieved Adequate Response

Clinical Scenario

This protocol applies to women aged 18 years or older with androgenetic alopecia who have no clinical or biochemical evidence of hyperandrogenism (normoandrogenic). When first-line treatment has not met the defined therapeutic goals, a structured next-line approach is indicated.

Previous Line — Insufficient Response

Initial management in this population includes topical minoxidil (2% solution or 5% foam applied to the scalp). When six-month assessment shows that hair loss has not stopped and meaningful hair regrowth has not been induced, escalation to the next protocol line is warranted.

Next-Line Approach (Partial Overview)

For appropriately selected patients, a surgical hair restoration procedure may be considered — reserved for those who meet a specific donor-hair criterion. The complete eligibility criteria, patient selection steps, and clinical algorithm are available only in the full protocol.

Treatment Goal

The primary objective is cosmetic recovery of hairless areas. Outcome is formally evaluated at 9 to 12 months following the intervention.

Instant Access to Structured Evidence-Based Regimens

References

Topical Minoxidil 2% solution 1 mL twice daily or half a cap of 5% minoxidil topical foam once daily is recommended to improve or to prevent progression of AGA in female patients above 18 years with AGA.
Surgery especially follicular unit transplantation (FUT) can be considered in female patients with sufficient donor hair.
The final result can be evaluated at 9–12 months.

DOI: 10.1111/jdv.14624

View source ↗